JP2019513692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019513692A5 JP2019513692A5 JP2018543636A JP2018543636A JP2019513692A5 JP 2019513692 A5 JP2019513692 A5 JP 2019513692A5 JP 2018543636 A JP2018543636 A JP 2018543636A JP 2018543636 A JP2018543636 A JP 2018543636A JP 2019513692 A5 JP2019513692 A5 JP 2019513692A5
- Authority
- JP
- Japan
- Prior art keywords
- monomer
- terminal arm
- conjugated
- terminal
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022078004A JP7516459B2 (ja) | 2016-02-19 | 2022-05-11 | 核酸キャリア及び治療上の使用方法 |
| JP2024067893A JP2024099661A (ja) | 2016-02-19 | 2024-04-19 | 核酸キャリア及び治療上の使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662297200P | 2016-02-19 | 2016-02-19 | |
| US62/297,200 | 2016-02-19 | ||
| PCT/US2017/018343 WO2017143171A1 (en) | 2016-02-19 | 2017-02-17 | Nucleic acid carriers and therapeutic methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022078004A Division JP7516459B2 (ja) | 2016-02-19 | 2022-05-11 | 核酸キャリア及び治療上の使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019513692A JP2019513692A (ja) | 2019-05-30 |
| JP2019513692A5 true JP2019513692A5 (enExample) | 2020-03-12 |
Family
ID=59626355
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018543636A Pending JP2019513692A (ja) | 2016-02-19 | 2017-02-17 | 核酸キャリア及び治療上の使用方法 |
| JP2022078004A Active JP7516459B2 (ja) | 2016-02-19 | 2022-05-11 | 核酸キャリア及び治療上の使用方法 |
| JP2024067893A Pending JP2024099661A (ja) | 2016-02-19 | 2024-04-19 | 核酸キャリア及び治療上の使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022078004A Active JP7516459B2 (ja) | 2016-02-19 | 2022-05-11 | 核酸キャリア及び治療上の使用方法 |
| JP2024067893A Pending JP2024099661A (ja) | 2016-02-19 | 2024-04-19 | 核酸キャリア及び治療上の使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US12076410B2 (enExample) |
| EP (1) | EP3416691A4 (enExample) |
| JP (3) | JP2019513692A (enExample) |
| AU (2) | AU2017221437A1 (enExample) |
| WO (1) | WO2017143171A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017143156A1 (en) | 2016-02-19 | 2017-08-24 | Genisphere Llc | Nucleic acid carriers and therapeutic methods of use |
| WO2017189805A1 (en) | 2016-04-27 | 2017-11-02 | Abbvie Inc. | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| BR112019021520A2 (pt) | 2017-04-14 | 2020-08-04 | Tollnine, Inc. | oligonucleotídeo, composto, polinucleotídeo imunomodulador, composição, conjugado, método para modular um receptor, método de tratamento de um tumor, método de tratamento de câncer, método para tratar um tumor, método de prevenção de câncer, método para induzir uma resposta imune |
| KR102795781B1 (ko) | 2017-06-16 | 2025-04-15 | 듀크 유니버시티 | 개선된 라벨 검출, 계산, 분석물 감지, 및 조정 가능한 난수 생성을 위한 공진기 네트워크 |
| EP3759225A1 (en) | 2018-03-02 | 2021-01-06 | Sixfold Bioscience Ltd. | Compositions for delivery of cargo to cells |
| EP3765094A4 (en) | 2018-03-15 | 2021-12-22 | KSQ Therapeutics, Inc. | GENE REGULATORY COMPOSITIONS AND PROCEDURES FOR IMPROVED IMMUNOTHERAPY |
| AU2019360216A1 (en) * | 2018-10-17 | 2021-05-13 | Tallac Therapeutics, Inc. | Immunomodulating polynucleotide conjugates and methods of use |
| CN110092826B (zh) * | 2019-02-28 | 2022-04-15 | 天津大学 | CTLA-4类似物CFN13及CFN13-Fc基因和蛋白 |
| WO2020200481A1 (en) * | 2019-04-05 | 2020-10-08 | Biontech Rna Pharmaceuticals Gmbh | Treatment involving interleukin-2 (il2) and interferon (ifn) |
| WO2021053405A2 (en) | 2019-08-30 | 2021-03-25 | Sixfold Bioscience Ltd. | Compositions for transfer of cargo to cells |
| JP7777524B2 (ja) | 2019-11-04 | 2025-11-28 | コード バイオセラピューティクス インコーポレイテッド | 脳特異的血管新生抑制因子１（ｂａｉ１）抗体及びその使用 |
| IL295759A (en) | 2020-02-28 | 2022-10-01 | Tallac Therapeutics Inc | Transglutaminase mediated coupling |
| CN115997016A (zh) | 2020-04-27 | 2023-04-21 | 西克斯福德生物科学有限公司 | 包含具有模块化官能团的核酸纳米颗粒的组合物 |
| CN119095602A (zh) * | 2022-02-10 | 2024-12-06 | 代码生物疗法公司 | 增强的dna树枝状聚合物及其使用方法 |
| WO2025038373A1 (en) * | 2023-08-11 | 2025-02-20 | Unm Rainforest Innovations | Compositions and methods targeting osteoactivin |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9504664A (es) * | 1994-03-07 | 1997-05-31 | Dow Chemical Co | Conjugados de dendrimeros bioactivos y/o dirigidos. |
| AU8601898A (en) * | 1997-07-29 | 1999-02-22 | Polyprobe, Inc. | Dendritic nucleic acids exhibiting maximal self-assembly |
| US6287765B1 (en) | 1998-05-20 | 2001-09-11 | Molecular Machines, Inc. | Methods for detecting and identifying single molecules |
| KR100985457B1 (ko) | 2001-06-21 | 2010-10-06 | 다이나박스 테크놀로지 코퍼레이션 | 키메라 면역조절 화합물 및 그것들의 사용 방법 |
| AU2003243562A1 (en) | 2002-06-12 | 2003-12-31 | Datascope Investment Corp. | Polymeric label molecules |
| NZ540098A (en) * | 2002-10-29 | 2008-09-26 | Coley Pharmaceutical Group Ltd | Use of CPG oligonucleotides in the treatment of hepatitis C virus infection |
| US7956043B2 (en) * | 2002-12-11 | 2011-06-07 | Coley Pharmaceutical Group, Inc. | 5′ CpG nucleic acids and methods of use |
| US20100136614A1 (en) | 2005-10-18 | 2010-06-03 | Dan Luo | Dendrimer-like modular delivery vector |
| WO2008144562A1 (en) | 2007-05-16 | 2008-11-27 | California Institute Of Technology | A versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways |
| EP3351270A1 (en) * | 2007-05-23 | 2018-07-25 | The Trustees of the University of Pennsylvania | Targeted carriers for intracellular drug delivery |
| EP2178896A1 (en) | 2007-07-31 | 2010-04-28 | The Johns Hopkins University | Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| AU2009279458B2 (en) * | 2008-08-08 | 2015-07-02 | Code Biotherapeutics, Inc. | Long-acting DNA dendrimers and methods thereof |
| US20110206611A1 (en) | 2010-02-24 | 2011-08-25 | Genisphere, Llc | DNA Dendrimers as Thermal Ablation Devices |
| US20130018086A1 (en) * | 2010-03-16 | 2013-01-17 | Massachusette Institute Of Technology | Sirnas targeting exon 10 of pyruvate kinase m2 |
| WO2012125987A2 (en) | 2011-03-17 | 2012-09-20 | Massachusetts Institute Of Technology | Delivery system |
| CA2871386A1 (en) | 2012-06-27 | 2014-01-03 | F. Hoffmann-La Roche Ag | Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereof |
| US9651549B2 (en) * | 2012-07-13 | 2017-05-16 | Genisphere, Llc | Lateral flow assays using DNA dendrimers |
| WO2014071379A1 (en) * | 2012-11-05 | 2014-05-08 | Pronai Therapeutics, Inc. | Dosing and administration of oligonucleotide cancer therapies |
| WO2014121050A1 (en) | 2013-02-01 | 2014-08-07 | Genisphere, Llc | Functionalized dna dendrimers for gene delivery to cells |
| JP6346265B2 (ja) | 2013-03-21 | 2018-06-20 | ジェニスフィア・エルエルシー | Ｄｎａインターカレーティング剤の細胞送達 |
| LT3074424T (lt) | 2013-11-27 | 2025-05-26 | Zymeworks Bc Inc. | Bispecifiniai antigeną surišantys konstruktai, nukreipti į her2 |
| EP3289084B1 (en) | 2015-04-17 | 2020-09-16 | Genisphere, LLC | siRNA INHIBITION OF HUMAN ANTIGEN R EXPRESSION FOR TREATMENT OF CANCER |
| WO2017143156A1 (en) * | 2016-02-19 | 2017-08-24 | Genisphere Llc | Nucleic acid carriers and therapeutic methods of use |
-
2017
- 2017-02-17 JP JP2018543636A patent/JP2019513692A/ja active Pending
- 2017-02-17 WO PCT/US2017/018343 patent/WO2017143171A1/en not_active Ceased
- 2017-02-17 AU AU2017221437A patent/AU2017221437A1/en not_active Abandoned
- 2017-02-17 US US15/999,781 patent/US12076410B2/en active Active
- 2017-02-17 EP EP17753912.9A patent/EP3416691A4/en active Pending
-
2022
- 2022-05-11 JP JP2022078004A patent/JP7516459B2/ja active Active
-
2024
- 2024-04-19 JP JP2024067893A patent/JP2024099661A/ja active Pending
- 2024-04-29 AU AU2024202764A patent/AU2024202764B2/en active Active
- 2024-07-24 US US18/782,174 patent/US20250049942A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019511474A5 (enExample) | ||
| JP7516459B2 (ja) | 核酸キャリア及び治療上の使用方法 | |
| JP7366541B2 (ja) | 核酸キャリア及び治療上の使用方法 | |
| Vandghanooni et al. | Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective | |
| CN112654346B (zh) | 生物分子包覆颗粒和薄膜及其用途 | |
| CN115003802B (zh) | 一种经修饰的免疫效应细胞及其制备方法 | |
| WO2011050000A2 (en) | Single molecule nucleic acid nanoparticles | |
| TWI771643B (zh) | 一種新穎的ｃｄ１６陽性自然殺手細胞及一種培養ｃｄ１６陽性自然殺手細胞的方法 | |
| JP2022542198A (ja) | アプタマーベース多重特異性治療剤 | |
| KR20260011768A (ko) | 압타머-기반 car t-세포 스위치 | |
| JP2024512004A (ja) | 操作されたキメラ融合タンパク質組成物およびその使用方法 | |
| KR20250107811A (ko) | 조작된 키메라 융합 단백질 조성물 및 그의 사용 방법 | |
| CN114395532B (zh) | 一种用于检测抗体-免疫激动剂偶联药物活性的细胞株和检测方法 | |
| Byrne et al. | Special conference on tumor immunology and immunotherapy: a new chapter | |
| Yuan et al. | CD8+ T Cells in Gastrointestinal Cancer: a Perspective on Targeting MicroRNA | |
| CN118812724A (zh) | 嵌合型趋化因子受体的应用 | |
| CN117425481A (zh) | 工程化嵌合融合蛋白组合物及其使用方法 | |
| Xu et al. | Surface Functionalization of Extracellular Vesicles with Nucleic Acids towards Biomedical Applications | |
| JP2025504036A5 (enExample) | ||
| CN118374456A (zh) | 改造的免疫细胞、靶向BRD9基因的gRNA和应用 | |
| CN115386581A (zh) | 一种特异性结合ox40蛋白的核酸适配体及其应用 | |
| WO2023081767A1 (en) | Methods for immunotherapy | |
| WO2025224074A1 (en) | Improved engineered immune cell therapies | |
| HK40112579A (en) | Nucleic acid-polypeptide compositions and uses thereof | |
| WO2023152382A1 (en) | Artificial microrna construct |